Antithrombotic Properties of RWJ-50353, a Potent and Novel Thrombin Inhibitor*
- 1 April 2000
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 98 (1), 83-93
- https://doi.org/10.1016/s0049-3848(99)00219-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Successors to heparin: New antithrombotic agentsAmerican Heart Journal, 1997
- The therapeutic potential of novel anticoagulantsExpert Opinion on Investigational Drugs, 1997
- Direct Thrombin Inhibitors: Appraisal of the Antithrombotic/ Hemorrhagic BalanceThrombosis and Haemostasis, 1997
- New Approaches to Prevention of Deep Vein ThrombosisThrombosis and Haemostasis, 1997
- Coagulation factors and their inhibitorsCurrent Opinion in Structural Biology, 1994
- Regulation of Thrombin Activity by Antithrombin and HeparinSeminars in Thrombosis and Hemostasis, 1994
- Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profileTrends in Pharmacological Sciences, 1993
- Antithrombins: Their Potential as Antithrombotic AgentsAnnual Review of Medicine, 1992
- Thrombin antagonists and antiplatelet agentsThe American Journal of Cardiology, 1992
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991